This website is a resource on Advance Market Commitments (AMC), an innovative finacing mechanism, as well as the pilot AMC for pneumococcal disease. The website contains information on what is an AMC and how manufacturers can particpate in …

This informative fact sheet provides a definition of Advance Market Commitments as a potential financing mechanism for bringing new vaccines to the developing world and also outlines World Health Organization's position on the mechanism.

The Advanced Immunization Management e-Learning tool is designed to provide comprehensive information to support immunization program managers at all stages of country-level decision-making. This module is designed to teach senior immunization …

The Advanced Immunization Management e-Learning tool is designed to provide comprehensive information to support immunization program managers at all stages of country-level decision-making. This module on rotavirus provides training on topics …

Developed by PATH and Stanford University, the Advanced Immunization Management (AIM) e-Learning tool is designed to provide comprehensive information to support immunization program managers at all stages of country-level decision-making. The …

This report discusses the work of PATH's Children's Vaccine Program and the Indian state of Andhra Pradesh to build a model immunization program, including the incorporation of hepatitis B vaccine into the childhood vaccination program.

This report estimates the burden and costs of pneumococcal disease in Latin America and the Caribbean in order to inform national health authorities about disease burden and the economic value of implementing a pneumococcal …

This report discusses the work of PATH's Children's Vaccine Program and the Australian International Health Institute of the University of Melbourne to provide technical assistance with immunization programming to Cambodia, including the …

Partners in Health for Reform Plus, in collaboration with WHO and the Morrocan Ministry of Health, conducted an in-depth study of the costs and financing of immunization, and their report offers options in the areas of program planning, management, …

This study estimates the current and future costs of Ghana's immunization program, including the additional costs proposed for improvements to the program, both to assist planning and to inform the international community about global immunization …

This report from the WHO's Weekly Epidemiologic Record summarizes a meeting convened by PATH, WHO, and the US Centers for Disease Control and Prevention (CDC) on the economic burden of rotavirus disease and cost-effectiveness of vaccines. The …

This paper summarizes the results of a WHO/UNICEF study on the potential impact of immunization over the next decade and the financing required for immunization activities in the 72 poorest countries of the world.

This review, published in the Journal of the American Medical Association, analyzed the cost-effectiveness of rotavirus vaccine introduction from the perspective of health care systems and society.

Published in the Journal of Pharmaceutical Finance, Economics & Policy, this article evaluates the potential use of vaccines against Japanese encephalitis (JE) and estimates the cost-effectiveness of mass vaccination campaigns and routine …

This study, published in the journal Pediatrics, examines the costs and benefits of routine rotavirus vaccination for infants in the US, using a hypothetical cohort of unvaccinated infants. Researchers determined that, at current prices, …

This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine …

This article, published in Expert Review Pharmacoeconomics Outcomes Research, reviews economic evaluations of Rotarix® and RotaTeq® and offers suggestions for future analyses of cost-effectiveness. ABSTRACT ONLY. (Learn how users in …

From the Bulletin of the World Health Organization, this article investigates the cost-effectiveness of JE immunization in China and demonstrates that a JE immunization program can be a cost-saving intervention for countries.

Investigators found that rotavirus gastroenteritis incurs considerable use of health care resources and results in substantial costs for families of patients and employers. Routine rotavirus vaccination could significantly reduce the related …

This paper outlines the role of developing country vaccine manufacturers in global efforts to increase access to vaccines.

A comprehensive global health examination, Disease Control Priorities in Developing Countries contributes substantially to global initiatives to improve the health of all peoples by providing a multidisciplinary understanding of fundamental …

This fascinating special report focuses on the immunization and health-related initiatives supported by the Bill & Melinda Gates Foundation and the reasons for choosing these programs.

This framework serves as a guide for planning for and conducting global and national decision-making on the introduction of a future malaria vaccine. The document also describes processes and activities that led to the development of …

This study, published in Bulletin of the World Health Organization, discusses the introduction of Hib vaccine in Kenya, one of the first nine countries to receive financial support from GAVI for Hib vaccine introduction. The objective of this study …

This paper, published in the Journal of Public Health, evaluates the cost-effectiveness of introducing Hib vaccine in Indonesia as an addition to the country's current DTP–Hepatitis B vaccination program.